Save time and get answers to complex questions with AI chat
Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Does lipitor's use influence blood pressure medication type?The expiration date of the key patent for guselkumab?What excipients are combined with ruxolitinib in apotex's medication?Bivalirudin manufacturer?
See the DrugPatentWatch profile for rifampin
Short answer: No clinically significant interaction is expected. Rifampin does not meaningfully reduce the effectiveness of famciclovir. Why: - Famciclovir is a prodrug that is converted to penciclovir by esterases (not by CYP450 enzymes). - Penciclovir is eliminated mainly by the kidneys (renal excretion), not by hepatic metabolism that rifampin would induce. - Rifampin is a potent inducer of many hepatic enzymes and some transporters, but this does not typically lower famciclovir/penciclovir exposure in a meaningful way. Practical points: - If both drugs must be used together, there’s no standard dose adjustment for famciclovir based on rifampin interactions. - Monitor for persistent or recurrent herpes symptoms; if therapy seems less effective, consult the clinician for reevaluation. - If you’re concerned about drug interactions in a specific patient (e.g., with kidney issues or polypharmacy), check a current drug interaction resource or with a healthcare professional.
Other Questions About Rifampin :